Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study

Fig. 2

Proportion of patients who achieved Well-Controlled* (a) and Total-Control of* (b) asthma. *Phase I data are presented by dose and Phase II data are overall proportions only. FP fluticasone propionate, ICS inhaled corticosteroid, S1 patients who were ICS naïve at study entry, S2 patients who received low-dose ICS treatment prior to study entry, S3 patients who received medium-dose ICS treatment prior to study entry, SAL salmeterol

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us